Cargando…
A dysglycaemic effect of statins in diabetes: relevance to clinical practice?
In this issue of the journal, Erqou and colleagues (DOI 10.1007/s00125-014-3374-x) report, in a systematic review and meta-analysis of randomised trials, a very modest (1.3 mmol/mol or 0.12%) albeit significant increase in HbA(1c) in patients with diabetes treated with statins, compared with control...
Autores principales: | Swerdlow, Daniel I., Sattar, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218973/ https://www.ncbi.nlm.nih.gov/pubmed/25335441 http://dx.doi.org/10.1007/s00125-014-3409-3 |
Ejemplares similares
-
IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk
por: Yiannakouris, N., et al.
Publicado: (2012) -
Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients
por: Ikonomidis, Ignatios, et al.
Publicado: (2022) -
C-Reactive Protein and Prognosis in Diabetes: Getting to the Heart of the Matter
por: Sattar, Naveed, et al.
Publicado: (2009) -
Are normoglycaemic individuals at risk of depression? The depression-dysglycaemic phenotype from a European population-based cross-sectional study
por: Cuschieri, Sarah, et al.
Publicado: (2020) -
Research on placebo analgesia is relevant to clinical practice
por: Gay, Charles W, et al.
Publicado: (2014)